a team of researchers at the université de montréal has identified a potential drug target that could safely slow down the progression of multiple sclerosis , a debilitating disease of the central nervous system that has afflicted more than 77,000 canadians.
“by blocking this molecule in mice, we were able to reduce the flow of b cells into their brains and, as a result, slow the progression of the disease,” said dr. alexandre prat, a neuroscientist at the centre de recherche du chum , and one of the authors of the study.
advertisement
canada has one of the highest rates of ms in the world, with an estimated one in every 385 canadians living with the disease. symptoms can include fatigue, lack of coordination, vision problems, cognitive impairment and mood changes.
advertisement